Policy and Legislation
The Australian biotech firm's largest share holder is Rep. Chris Collins; HHS Secretary Tom Price sold his shares earlier this year.
The Food and Drug Administration on Wednesday approved acute lymphoblastic leukemia treatment Kymriah, that comes with a $475,000 price tag.
AHA is concerned with the underlying data used to determine the DSH payments.
The ideas that have been floating around Washington right now include Medicare at 55, 'buying' into Medicaid and changing HSA rules.
High performing ACOs maintained a high use of primary care services and reduced spending by an average of $673 per beneficiary.
CMS has waived document requirements to ensure medical facilities can deliver care to displaced individuals.
Insurers pulling out of market has prompted law to help seriously ill patients keep doctors even if they don't contract with new health plan.
Ohio's insurance department will work with insurers to finalize the products and rates that will be available in 2018.
"I'm not sure" was the most common response to every question in this year's survey, NueMD said.
The number of consumers in these plans has dropped from 330,000 to 50,000, and those that remain have gotten older and sicker without new customers to balance the risk pool, according to the insurer.